Cyclerion Therapeutics - Stock Price History | CYCN

Historical daily share price chart and data for Cyclerion Therapeutics since 2021 adjusted for splits. The latest closing stock price for Cyclerion Therapeutics as of September 27, 2021 is 3.44.
  • The all-time high Cyclerion Therapeutics stock closing price was 18.46 on April 10, 2019.
  • The Cyclerion Therapeutics 52-week high stock price is 7.19, which is 109% above the current share price.
  • The Cyclerion Therapeutics 52-week low stock price is 2.08, which is 39.5% below the current share price.
  • The average Cyclerion Therapeutics stock price for the last 52 weeks is 3.40.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Cyclerion Therapeutics Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 4.2235 2.5700 8.3900 2.2500 3.0600 12.50%
2019 9.8282 14.4900 18.4600 1.8000 2.7200 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.149B $0.002B
Cyclerion Therapeutics Inc. is a clinical-stage biopharmaceutical company harnessing the power of sGC pharmacology to discover, develop and commercialize breakthrough treatments for serious and orphan diseases. The company's product pipeline consists of Olinciguat, Praliciguat and IW-6463 which are in clinical stage. Cyclerion Therapeutics Inc. is based in Cambridge, United States.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $132.971B 8.85
Bio-Rad Laboratories (BIO.B) United States $22.624B 48.22
QIAGEN (QGEN) Netherlands $12.001B 20.32
Biohaven Pharmaceutical Holding (BHVN) United States $8.691B 0.00
Emergent Biosolutions (EBS) United States $2.870B 6.92
Arcus Biosciences (RCUS) United States $2.690B 0.00
Myovant Sciences (MYOV) United Kingdom $2.182B 0.00
ADC Therapeutics SA (ADCT) Switzerland $2.045B 0.00
Zymeworks (ZYME) Canada $1.373B 0.00
Ambrx Biopharma (AMAM) United States $0.501B 0.00
SQZ Biotechnologies (SQZ) United States $0.442B 0.00
Enzo Biochem (ENZ) United States $0.174B 51.29